The coronavirus SARS-CoV-2 (SARS-CoV-2)
grew fast to become a global pandemic and a dreaded disease since its emergence
in 2019. This work looks at the hematological manifestation and its effect on
some hematological disorders.
The infection through multiple pathways
resulted in lymphopenia, thrombocytopenia, thrombosis and multiple unique
cellular changes seen following COVID-19 infections. COVID-19 can cause severe
illness and death in people with a history of sickle cell disease (SCD).
Patients with thalassemia are at increased risk of developing severe illness
from respiratory infections, including COVID-19, than people without SCD.
Individuals diagnosed with leukemias and other hematological malignancies also
demonstrated increased adverse outcomes following infection with COVID-19
infections. Vaccine-induced thrombosis (VITT), a condition that has been
associated with a specific type of vaccine rapidly came to light following the
widespread vaccine campaign to control the spread of the virus.
Author(s)
Details:
Aliyu
Dahiru Waziri
Department of Haematology and Blood Transfusion,
Faculty of Basic Clinical Sciences, College of Medical Science, Ahmadu Bello
University/Teaching Hospital, Zaria, Nigeria.
Emmanuel
Akoyi Akor
Department of Haematology and Transfusion Medicine,
Jos University Teaching Hospital (JUTH), Prozone Diagnostic Laboratory, Jos,
Nigeria.
Please see the book here: https://doi.org/10.9734/bpi/mono/978-81-973195-5-6/CH14
No comments:
Post a Comment